Mankind Pharma Limited — Credit Ratings, 13-11-2025: Credit Rating

ICRA has withdrawn Mankind Pharma's A1+ rating for ₹3,500 Cr Commercial Paper. The company maintains outstanding ratings, including (ICRA) AA+/Stable for ₹5,000 Cr Non-Convertible Debentures and (ICRA) A1+ for ₹1,500 Cr Commercial Paper. Additionally, ₹1,250 Cr long-term/short-term fund-based limits hold (ICRA) AA+ (Stable)/A1+ ratings.